Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 3;9(4):a023705.
doi: 10.1101/cshperspect.a023705.

Molecular Genetics of Neurodegenerative Dementias

Affiliations
Review

Molecular Genetics of Neurodegenerative Dementias

Flora I Hinz et al. Cold Spring Harb Perspect Biol. .

Abstract

Neurodegenerative dementias are clinically heterogeneous, progressive diseases with frequently overlapping symptoms, such as cognitive impairments and behavior and movement deficits. Although a majority of cases appear to be sporadic, there is a large genetic component that has yet to be fully explained. Here, we review the recent genetic and genomic findings pertaining to Alzheimer's disease, frontotemporal dementia, Lewy body dementia, and prion dementia. In this review, we describe causal and susceptibility genes identified for these dementias and discuss recent research pertaining to the molecular function of these genes. Of particular interest, there is a large overlap in clinical phenotypes, genes, and/or aggregating protein products involved in these diseases, as well as frequent comorbid presentation, indicating that these dementias may represent a continuum of syndromes rather than individual diseases.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Frequency of specific neurodegenerative dementias. The inner circle shows the frequency of specific neurodegenerative dementias (indicated by different colors) as an approximate percentage of all cases of disease. The middle circle shows the percentage of patients that show familial or sporadic patterns of inheritance for each disease. The outer circle depicts the approximate percent of patients with familial inheritance patterns that harbor mutations in specific known causal genes.
Figure 2.
Figure 2.
Neurodegenerative dementias as a spectrum disorder. Genes (left) and their pathologically aggregating protein products (right) and the neurodegenerative disorders (center) in which they have been implicated are shown.

References

    1. Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH. 2012. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol 124: 339–352. - PubMed
    1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185–188. - PubMed
    1. Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, DeJesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW III, Rademakers R, et al. 2013. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77: 639–646. - PMC - PubMed
    1. Ashford JW. 2004. APOE genotype effects on Alzheimer’s disease onset and epidemiology. J Mol Neurosci 23: 157–165. - PubMed
    1. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, et al. 2006. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442: 916–919. - PubMed

MeSH terms